Earl Howe
Main Page: Earl Howe (Conservative - Excepted Hereditary)Department Debates - View all Earl Howe's debates with the Ministry of Justice
(6 months, 4 weeks ago)
Lords ChamberMy Lords, I am very grateful for the opportunity to raise some issues that have arisen since the publication of the framework and tariffs for the new infected blood compensation scheme on Tuesday afternoon. I thank the noble Earl and John Glen for providing the details to make that possible, and the usual channels for ensuring that the work done so far is not lost but carried through.
However, over the last 24 hours, we have heard from a substantial number of members of the infected blood community who are distraught by the detail that has come out in the framework and tariffs, which seem to be at complete odds with the schemes that have gone before. I have a long shopping list of over 20 points; I will not detain the House with them, but I forwarded them to the Minister in advance of this debate. I will raise two or three as illustrations.
Under the new framework, there will be no distinction between chronic hepatitis B and C in calculating infection. There is no consistency about other diseases; for example, variant CJD has been left out of the new scheme but was included in the old one, as has Hodgkin lymphoma and possibly other cancers. Many people believe that the Government’s proposals still mean that the current schemes will be closed down, leaving them worse off, and that the Government have an incentive to wait longer to pay compensation. They need great reassurance and clarity that that will not be the case, because that is not evident in what was published on Tuesday afternoon.
Can the Government provide a breakdown of how the core route awards examples have been calculated? That would be helpful, even if only to say that there will be further information published online. There are concerns about the illustrative awards being worded as
“for a living infected person”
and not simply an “infected person”. Given that your Lordships’ House has debated a great deal of the wonderful news that estates will also be able to claim, does that mean that estates will be excluded from this part of the scheme?
Noble Lords can see that there is a lot of detail here. A community that thought, on Tuesday morning, that everything was going to be all right are now very concerned that there are a large number of anomalies that need to be corrected. I will not go on, except to say that I am really grateful for all the help that the Minister has given, and I hope that he can provide some reassurance.
My Lords, I thank my noble and learned friend Lord Bellamy, the ministerial team and everybody across the Chamber from different teams. It has been heartwarming to see everybody trying to get the best result for victims and their families and make sure that the system understands what their journey is about. I also thank the Bill team, whom I have worked with not just on this Bill but as Victims’ Commissioner. I am very proud to be able to work my way round in that role as well.
Most importantly, it was not very nice to have “victims and prisoners” on the Bill, but we are where we are. However, to understand what victims go through is very important. I give huge congratulations on not throwing the baby out with the bath-water in all the politics. This is about people and this legislation is so important. It is a driver for getting other things on to it, whoever gets into power. It is important never to forget that victims have a voice and that voice must always be listened to. That is, as legislators, how we make legislation far better as it goes through these Houses.
I thank the ministerial team and everybody else who has joined in support of these amendments.
My Lords, mindful that this is somewhat exceptional procedure at this stage of a Bill’s passage, I shall first address the points and questions raised by the noble Baroness, Lady Brinton, to whom I am grateful for the opportunity to provide some clarity on various aspects of the infected blood compensation scheme.
On Monday, as the House is aware, the infected blood inquiry published its final report. By any standards, this was a very significant day. As the Prime Minister said, the report shows a decades-long moral failure at the heart of our national life. So the importance of ensuring that we provide a clear commitment from all sides of the House, as I believe there is, on doing what is right for the infected and affected victims, cannot be overstated. We must progress this legislation and we must continue to engage with the infected blood community on the details of the proposed scheme, ahead of those details being set in regulation. I hope that all parties join me in that sentiment.
I turning to the specific questions raised by the noble Baroness, Lady Brinton. On the issue of interim payments, I reassure her that this legislation still provides for the duty of interim payments to the estates of deceased infected people where payments were not previously received. In addition, a further interim payment of £210,000 is being made to living infected persons in recognition that this will meet the needs of those most likely to be disadvantaged by the passage of time. This payment will be delivered separately by the infected blood support schemes.
The Government are working to deliver these payments to the living infected as a matter of urgency. This morning, the Department of Health and Social Care laid a Written Ministerial Statement to seek a contingencies fund advance to make these payments in England and the Minister for the Cabinet Office met the relevant Health Ministers in Scotland, Wales and Northern Ireland to discuss these operational details. We are working with the devolved Administrations to make these payments swiftly across the UK and I am assured that we share a joint determination to make them as swiftly as possible. Once we have finalised the process with the devolved Administrations, those due to receive these payments will receive details of the date of payment directly from the infected blood support scheme that they are registered with. All interim compensation payments will be deducted from any final payment.
The noble Baroness raised questions on the definition of hepatitis C and related matters. In line with the recommendations of the infected blood inquiry, those infected with hepatitis C will be eligible for compensation, and this includes those whose infection lasted less than six months and those whose infection became chronic—by which we mean it lasted more than six months. Those who had a chronic hepatitis infection that has now cleared as a result of successful treatment will still be eligible to claim compensation.
On the questions that the noble Baroness raised on how the core route has been calculated and the other conditions which indicate hepatitis C progression, let me reassure her that, as announced by the Minister for the Cabinet Office in another place, Sir Robert Francis will now conduct an engagement exercise with the community before regulations to establish the scheme are made, and further details on that will be released shortly.
The noble Baroness also asked why the illustrative tables provide figures for living infected persons only. This is because awards in relation to deceased persons with an infection have a much greater degree of variability depending, for example, on the duration of their illness before they passed away. Publishing an illustrative table for deceased persons, given that awards will differ quite markedly depending on individual circumstances, would not be very helpful.
Compensation with regard to a deceased individual will be distributed to the estate, as the noble Baroness mentioned, and bereaved partners and other affected dependants. The Government are also providing a technical briefing with key representatives of the infected blood community to explain the Government’s proposals, as set out on GOV.UK, and I am confident that will be a useful discussion.
The noble Baroness asked a further question about financial loss incurred by affected dependants of a deceased infected person. Where an infected person has, sadly, died, those who were reliant on them at the time of their death—for example, a partner or child under 18—will receive a financial loss award under the scheme to recognise this loss. On the duration of the blood support schemes, let me reassure the noble Baroness that the establishment of the scheme will not have any immediate impact on the support payments received through the infected blood support schemes and there will be no gap in the payments provided to beneficiaries.
The support schemes are delivered separately in England, Wales, Scotland and Northern Ireland and decisions on individual schemes will be for the devolved Administrations. No one will be worse off under the final compensation scheme than they would have been under existing support schemes. However, the infected blood compensation scheme will compensate for both past and future losses suffered as a result of infected blood.
Once assessed under the scheme, the applicant will be able to choose how to receive their compensation, as either a lump sum or periodic payments. This means that those who value the security of a regular payment will be able to receive compensation in this way. I hope that clarification is helpful.
In the event that the infected blood compensation authority assesses that a person is entitled to less compensation through the compensation scheme than would otherwise have been paid to them through continued infected blood support scheme payments, an additional top-up payment will be provided to bring the compensation they receive up to the level of the support payments. Any top-up payment awarded will take into account other compensation payments that a person has received through the scheme, either in their own right or as an estate beneficiary. This will ensure that no one will receive less compensation through the compensation scheme than they would have received through the payments to which they would otherwise have been entitled through existing support schemes.
I hope my words have provided reassurance to the noble Baroness, and, more widely, to the infected blood community, many of whom have followed the passage of this legislation with close attention. As we have seen throughout the passage of the Bill, and following the announcements this week, there is cross-party agreement to progress work on infected blood, and the Government will continue to deliver what was set out on Tuesday.
As we reach the concluding stages of the Victims and Prisoners Bill, I express my gratitude, and that of my noble and learned friend Lord Bellamy and my noble friend Lord Roborough, to noble Lords on all sides of the House for their amendments, engagement and collaboration throughout the passage of this Bill. Through its stages in this place, between us we have made vital changes to strengthen code compliance measures for victims, establish the body to pay compensation to victims of the infected blood scandal, and bring forward a package of reforms for those sentenced to imprisonment for public protection sentences. I am confident that the Bill leaves this House as a package that truly delivers for victims and the public.
In expressing my thanks to noble Lords, I am mindful of the difficulty of singling out colleagues by name, but I extend particular thanks to the Victims’ Commissioner, my noble friend Lady Newlove, whose expertise has been vital throughout these stages.
Lastly, I express my deep gratitude, and that of my noble and learned friend Lord Bellamy and my noble friend Lord Roborough, to members of the Bill team and all officials in the Cabinet Office, whose hard work and professionalism have been exemplary. Were it not contrary to custom and practice, I would mention them by name.
This is important legislation, and I am pleased that it will make it to the end of its parliamentary passage ahead of Dissolution. I beg to move that the Bill do now pass.